OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
Shurong Ma, Qian Tong, Yuan Lin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 700

Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Jiaqiang Wu, Kangping Yang, Hancheng Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 63

Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Luis A. Constantino‐Jonapa, Yoshua Espinoza-Palacios, Alma Reyna Escalona‐Montaño, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 431-431
Open Access | Times Cited: 43

Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2

Berberine and health outcomes: An umbrella review
Zhongyu Li, Wang Yang, Qing Xu, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 5, pp. 2051-2066
Closed Access | Times Cited: 39

The potential role of plant secondary metabolites on antifungal and immunomodulatory effect
Xuedong Zhou, Meng Zeng, Fujiao Huang, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 14, pp. 4471-4492
Open Access | Times Cited: 25

Gut microbiota-derived trimethylamine N-Oxide: a novel target for the treatment of preeclampsia
Jiayi Wang, Yajie Gao, Shuaijun Ren, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 13

Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance
Yumeng Wang, Chengxi Li, Jianping Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3901-3915
Open Access | Times Cited: 13

Puerarin alleviates atherosclerosis via the inhibition ofPrevotella copriand its trimethylamine production
Z H Li, Jun Weng, Jing‐Kun Yan, et al.
Gut (2024) Vol. 73, Iss. 12, pp. 1934-1943
Closed Access | Times Cited: 12

Berberine as a novel ACSL4 inhibitor to suppress endothelial ferroptosis and atherosclerosis
Yang Hong, Jing Feng, Zijia Dou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117081-117081
Open Access | Times Cited: 11

Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Peng Yuan, Ruyi Qu, Shuqin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24619-e24619
Open Access | Times Cited: 10

Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E–deficient mice
Mengyun Xu, Jingjing Xu, Lijing Kang, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 10

Fecal bacteria transplantation replicates aerobic exercise to reshape the gut microbiota in mice to inhibit high-fat diet-induced atherosclerosis
Jie Men, Hao Li, Chenbin Cui, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0314698-e0314698
Open Access | Times Cited: 1

Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
Li-Bin Pan, Hang Yu, Jie Fu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1537-1553
Open Access | Times Cited: 31

Emerging trends and research foci of berberine on tumor from 2002 to 2021: A bibliometric article of the literature from WoSCC
Runzhu Yuan, Yao Tan, Ping‐Hui Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22

Baicalin ameliorates multidrug-resistant Pseudomonas aeruginosa induced pulmonary inflammation in rat via arginine biosynthesis
Lei Li, Herong Cui, Yue Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114660-114660
Open Access | Times Cited: 21

Recent advances in gut microbiota-associated natural products: structures, bioactivities, and mechanisms
Huanqin Dai, Junjie Han, Tao Wang, et al.
Natural Product Reports (2023) Vol. 40, Iss. 6, pp. 1078-1093
Closed Access | Times Cited: 18

The Roles of Periodontal Bacteria in Atherosclerosis
Xiaofei Huang, Mengru Xie, Xiaofeng Lu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12861-12861
Open Access | Times Cited: 18

Impact of the gut microbiome on atherosclerosis
Y. Mao, Chao Kong, Tongtong Zang, et al.
mLife (2024) Vol. 3, Iss. 2, pp. 167-175
Open Access | Times Cited: 6

Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review
Yujuan Li, Shengjie Yang, Xiao Jin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14

Exosomes‐transferred LINC00668 Contributes to Thrombosis by Promoting NETs Formation in Inflammatory Bowel Disease
Long Zhang, Bin Zheng, Yang Bai, et al.
Advanced Science (2023) Vol. 10, Iss. 28
Open Access | Times Cited: 14

Berberine promotes the degradation of phenylacetic acid to prevent thrombosis by modulating gut microbiota
Hao-Jian Zhang, Jie Fu, Hang Yu, et al.
Phytomedicine (2024) Vol. 128, pp. 155517-155517
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top